PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : N

Records returned : 71 (on 17 May 2024 at 09:24:54).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
04.06.00
Nabilone
Nausea and vomiting (chemotherapy induced)
Red
Formulations :
  • Capsules
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
CD
10.01.01
Nabumetone
Pain & inflammation - musculoskeletal
Non Formulary
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Nadolol
No Information Returned
Nadolol with diuretic
No Information Returned
06.07.02
Nafarelin acetate
Transgender Health - adults
Amber
Formulations :
  • Nasal spray
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF SPC
Un
Naftidrofuryl oxalate
No Information Returned
Nalbuphine hydrochloride
No Information Returned
01.06.06
Naldemedine
Constipation
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
R
NICE
Important
Opioid-induced constipation. Only after other laxatives have been unsuccessful.
Nalidixic acid
No Information Returned
Nalmefene
No Information Returned
Naloxegol
No Information Returned
Naloxone hydrochloride
No Information Returned
01.06.06
04.10.03
Naltrexone hydrochloride
Multiple sclerosis
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Un
04.05.01
Naltrexone with bupropion
Weight management in adults
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NFD1
NICE
Naltrexone/bupropion
No Information Returned
Nandrolone decanoate
No Information Returned
Naphazoline hydrochloride
No Information Returned
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Preferred
10.01.01
Naproxen
Dysmenorrhoea
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Green (see narrative)
Formulations :
  • Effervescent tablets
  • Oral suspension
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
R
Important
Effervescent tablets and oral suspension are much more expensive and should be reserved for patients in whom ibuprofen suspension is not suitable. Reserve oral suspension for patients with sodium restriction or for children.
10.01.01
Naproxen
Pain & inflammation - musculoskeletal
Non Formulary
Formulations :
  • Gastro-resistant tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Important
More expensive that standard tablets and offer no additional gastro-protection.
Naproxen sodium
No Information Returned
01.03.05
10.01.01
Naproxen with esomeprazole
Pain & inflammation - musculoskeletal
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
04.07.04
Naratriptan hydrochloride
Migraine (acute)
Green
Formulations :
  • Tablets
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Important
Preferred
Prescribe generically
Natalizumab
No Information Returned
Natamycin
No Information Returned
Nateglinide
No Information Returned
Nebivolol
No Information Returned
Nedocromil sodium
No Information Returned
Nefazodone hydrochloride
No Information Returned
Nefopam hydrochloride
No Information Returned
Nelarabine
No Information Returned
Nelfinavir mesilate
No Information Returned
Neomycin sulfate
No Information Returned
10.02.01
Neostigmine bromide
Myasthenia gravis
Red
Formulations :
  • Injection
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
Neostigmine metilsulfate
No Information Returned
Nepafenac
No Information Returned
Netilmicin sulfate
No Information Returned
Netupitant/palonosetron hydrochloride
No Information Returned
Nevirapine
No Information Returned
Nicardipine hydrochloride
No Information Returned
Nicorandil
No Information Returned
Nicotinamide
No Information Returned
Nicotinates
No Information Returned
Nicotine
No Information Returned
Nicotine bitartrate
No Information Returned
Nicotinic acid
No Information Returned
Nicotinic acid derivatives
No Information Returned
Nicotinic acid/laropiprant
No Information Returned
Nifedipine
No Information Returned
Nifurtimox
No Information Returned
Nilotinib
No Information Returned
Nimodipine
No Information Returned
Nintedanib
No Information Returned
Niraparib
No Information Returned
Nirmatrelvir with Ritonavir
No Information Returned
Nisoldipine
No Information Returned
Nitazoxanide
No Information Returned
Nitisinone
No Information Returned
Nitrazepam
No Information Returned
Nitrofurantoin
No Information Returned
Nitrous oxide
No Information Returned
Nivolumab
No Information Returned
Nizatidine
No Information Returned
Nonoxinol 9
No Information Returned
Noradrenaline acid tartrate
No Information Returned
Norethisterone
No Information Returned
Norethisterone enantate
No Information Returned
Norfloxacin
No Information Returned
Norgestrel
No Information Returned
Normal immunoglobulin (Gamma globulin)
No Information Returned
04.03.01
04.07.03
Nortriptyline
Pain (Neuropathic)
Non Formulary
Formulations :
  • Not Specified
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
Noxytiolin
No Information Returned
05.02.03
07.02.02
Nystatin
Candidiasis
Non Formulary
Formulations :
  • Pessaries
  • Vaginal cream
ASPH
RSCH
SASH
SABP
Primary Care
BNF SPC
NFD1
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More